Major drug price reforms head for Biden's signature as PhRMA weighs legal options

Major drug price reforms head for Biden's signature as PhRMA weighs legal options

Source: 
Endpoints
snippet: 

The fact that the new drug price negotiations for certain blockbuster Medicare drugs — due for a partisan thumbs up in the US House of Representatives on Friday and a signature from President Joe Biden soon after — don’t take effect until 2026 means there’ll be plenty of time for PhRMA and others in biopharma to weigh their legal options.